๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparative evaluation of ARDS patients with and without H1N1 infection at a tertiary care referral center

โœ Scribed by T. Samra; M. Pawar; A. Yadav


Book ID
118451149
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
87 KB
Volume
14
Category
Article
ISSN
1201-9712

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Predictors of adalimumab dose escalation
โœ Russell D. Cohen; Jeffrey R. Lewis; Hannah Turner; Laura E. Harrell; Stephen B. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 167 KB ๐Ÿ‘ 2 views

Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg subcutaneously every 14 days, some patients require